Follow the Diagnostyka S.A. share price and the full directors' dealings record of the company, a publicly traded company based in Poland. Shares are listed on the PL market, under the supervision of KNF. Operating in the Health Care sector, Diagnostyka S.A. has published 3 reports. Market capitalisation: €5.7bn. The latest transaction was filed on 18 May 2026 (Notification PDMR). The full history is accessible without an account.
Analysts rate Diagnostyka S.A. Buy (bullish), based on 6 analysts. Average price target: PLN 197.45.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Diagnostyka S.A. 是一家专注于医疗保健和制药领域的公司,提供医疗诊断服务。该公司在XWAR市场上市。